Systemic sclerosis associated pulmonary arterial hypertension: The pitfalls;Hypertension artérielle pulmonaire et sclérodermie systémique: Les pièges

Presse Medicale

Volumn 40, Issue SUPPL. 1, 2011, Pages

  Hachulla, Eric ^a   Launay, David ^a   Le Pavec, Jérôme ^b   Mouthon, Luc ^c   Guillevin, Loïc ^c   de Groote, Pascal ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c université Paris Cité   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART VENTRICLE EJECTION TIME; HUMAN; INFERIOR CAVA VEIN; LUNG ARTERY PRESSURE; LUNG INSUFFICIENCY; PULMONARY HYPERTENSION; SCREENING TEST; SYSTEMIC SCLEROSIS;

ALGORITHMS; HUMANS; HYPERTENSION, PULMONARY; PULMONARY VENO-OCCLUSIVE DISEASE; SCLERODERMA, SYSTEMIC;

EID: 79955544409     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(11)70007-0     Document Type: Article

References (38)

1. Humbert M., Sitbon O., Chaouat A., Bertocchi M., Habib G., Gressin V., et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006, 173:1023{Eth}30.
2. Simonneau G., Robbins I.M., Beghetti M., Channick R.N., Delcroix M., Denton C.P., et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009, 54(1 Suppl):S43-S54.
3. Hachulla E., Gressin V., Guillevin L., Carpentier P., Diot E., Sibilia J., et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005, 52:3792-3800.
4. Mukerjee D., St George D., Coleiro B., Knight C., Denton C.P., Davar J., et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003, 62:1088-1093.
5. Hachulla E., Launay D., Mouthon L., Sitbon O., Berezne A., Guillevin L., et al. Is pulmonary arterial hypertension really a late complication of systemic sclerosis?. Chest 2009, 136:1211-1219.
6. Hachulla E., de Groote P., Gressin V., Sibilia J., Diot E., Carpentier P., et al. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Arthritis Rheum 2009, 60:1831-1839.
7. Hachulla E., Bervar J.F., Launay D., Lamblin N., Perez T., Mouthon L., et al. Dyspnea upon exertion in systemic scleroderma: from symptom to etiological diagnosis. Presse Med 2009, 38:911-926.
8. Galiè N., Hoeper M.M., Humbert M., Torbicki A., Vachiéry J.L., Barbera J.A., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009, 30:2493-2537.
9. Avouac J., Kowal-Bielecka O., Pittrow D., Huscher D., Behrens F., Denton C.P., et al. Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group. Ann Rheum Dis 2010, 69:1360-1363.
10. Launay D., Sitbon O., Le Pavec J., Savale L., Tchérakian C., Yaïci A., et al. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil. Rheumatology (Oxford) 2010, 49:490-500.
11. Allanore Y., Meune C., Vonk M.C., Airo P., Hachulla E., Caramaschi P., et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis 2010, 69:218-221.
12. Akram M.R., Handler C.E., Williams M., Carulli M.T., Andron M., Black C.M., et al. Angi-ographically proven coronary artery disease in scleroderma. Rheumatology (Oxford) 2006, 45:1395-1398.
13. Hachulla A.L., Launay D., Gaxotte V., de Groote P., Lamblin N., Devos P., et al. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 2009, 68:1878-1884.
14. de Groote P., Gressin V., Hachulla E., Carpentier P., Guillevin L., Kahan A., et al. Evaluation of cardiac abnormalities by Doppler echocardiography in a large nation-wide multicentric cohort of patients with systemic sclerosis. Ann Rheum Dis 2008, 67:31-36.
15. Meune C., Vignaux O., Kahan A., Allanore Y. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies. Arch Cardiovasc Dis 2010, 103:46-52.
16. Mathai S.C., Hummers L.K., Champion H.C., Wigley F.M., Zaiman A., Hassoun P.M., et al. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum 2009, 60:569-577.
17. Condliffe R., Kiely D.G., Peacock A.J., Corris P.A., Gibbs J.S., Vrapi F., et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 2009, 179:151-157.
18. Weitzenblum E., Chaouat A., Canuet M., Kessler R. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases. Semin Respir Crit Care Med 2009, 30:458-470.
19. Launay D., Mouthon L., Hachulla E., Pagnoux C., de Groote P., Remy-Jardin M., et al. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. J Rheumatol 2007, 34:1005-1011.
20. Avouac J., Airo P., Meune C., Beretta L., Dieude P., Caramashi P., et al. Prevalence of the different types of pulmonary hypertension in systemic sclerosis: results from two large samples of European Caucasians and meta-analysis of five studies. J Rheumatol 2010, 37:2290-2298.
21. Chang B., Schachna L., White B., Wigley F.M., Wise R.A. Natural history of mildmoderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma. J Rheumatol 2006, 33:269-274.
22. Wells A.U., Steen V., Valentini G. Pulmonary complications: one of the most challenging complications of systemic sclerosis. Rheumatology (Oxford) 2009, 48(Suppl 3):iii40-iii44.
23. Arcasoy S.M., Christie J.D., Ferrari V.A., Sutton M.S., Zisman D.A., Blumenthal N.P., et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003, 167:735-740.
24. Cottin V., Le Pavec J., Prevot G., Mal H., Humbert M., Simonneau G., et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010, 35:105-111.
25. Cottin V., Nunes H., Mouthon L., Gamondes D., Lazor R., Hachulla E., et al. Arthritis Rheum 2011, 63:295-304.
26. Mandel J., Mark E.J., Hales C.A. Pulmonary veno-occlusive disease. Am J Respir Crit Care Med 2000, 162:1964-1973.
27. Dorfmüller P., Humbert M., Perros F., Sanchez O., Simonneau G., Muller K.M., et al. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 2007, 38:893-902.
28. Overbeek M.J., Vonk M.C., Boonstra A., Voskuyl A.E., Vonk-Noordegraaf A., Smit E.F., et al. Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: A distinctive vasculopathy. Eur Respir J 2009, 34:371-379.
29. Johnson S.R., Patsios D., Hwang D.M., Granton J.T. Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension. J Rheumatol 2006, 33:2347-2350.
30. Zhang L., Visscher D., Rihal C., Aubry M.C. Pulmonary veno-occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease. Rheumatol Int 2007, 27:1163-1165.
31. Lantuejoul S., Sheppard M.N., Corrin B., Burke M.M., Nicholson A.G. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: A clinicopathologic study of 35 cases. Am J Surg Pathol 2006, 30:850-857.
32. Montani D., Price L.C., Dorfmüller P., Achouh L., Jaïs X., Yaici A., et al. Pulmonary veno-occlusive disease. Eur Respir J 2009, 33:189-200.
33. Montani D., Achouh L., Dorfmuller P., Le Pavec J., Sztrymf B., Tchérakian C., et al. Pulmonary veno-occlusive disease: Clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore) 2008, 87:220-233.
34. Rabiller A., Jaïs X., Hamid A., Resten A., Parent F., Haque R., et al. Occult alveolar haemorrhage in pulmonary veno-occlusive disease. Eur Respir J 2006, 27:108-113.
35. Resten A., Maitre S., Humbert M., Rabiller A., Sitbon O., Capron F., et al. Pulmonary hypertension: Ct of the chest in pulmonary veno-occlusive disease. AJR Am J Roentgenol 2004, 183:65-70.
36. Holcomb B.W., Loyd J.E., Ely E.W., Johnson J., Robbins I.M. Pulmonary veno-occlusive disease: a case series and new observations. Chest 2000, 118:1671-1679.
37. Le Pavec J, Humbert M, Mouthon L, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Am J Respir Crit Care Med;181:1285-93.
38. Thabut G., Christie J.D., Ravaud P., Castier Y., Brugiere O., Fournier M., et al. Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: A retrospective analysis of registry data. Lancet 2008, 371:744-751.